Not Yet RecruitingNCT07728981
Biomarkers, Effectiveness, and Safety of Aflibercept 8mg Modified Fixed Dose Regimen in Treatment-Naïve nAMD Patients
EARLY_PHASE1 · 49 planned enrolment
- Countries listed
- 0
- Registry update
- July 27, 2026
Registry Intervention View
Aflibercept 8mg
Trial registrations containing the exact intervention label Aflibercept 8mg.
Exact registry label · Not reported
4 linked registrations
No aliases or equivalent products have been inferred.
Topics connected by trial metadata
0 linked registrations report posted results
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →Registered trials
CompletedNCT06683950
Switching to Aflibercept 8mg in Patients Showing Limited Response to Previous Treatment
PHASE4 · 35 planned enrolment
- Countries listed
- 1
- Registry update
- July 16, 2026
RecruitingNCT07640997
Real-world Study of Aflibercept 8 mg in nAMD
Phase not reported · 300 planned enrolment
- Countries listed
- 1
- Registry update
- June 11, 2026
Not Yet RecruitingNCT07340372
Home Monitoring in eAMD Treatment
Phase not reported · 80 planned enrolment
- Countries listed
- 1
- Registry update
- May 6, 2026